Genterpret helps pharmaceutical companies quickly and cost effectively gain access to genetic and clinical datasets linking genetics to drug response. We quickly enroll patients through direct outreach and partnerships with patient communities and have systems in place to rapidly collect and process genetic and clinical information. We charge $1,000 per patient at 50% gross margins. Currently, we are in advanced discussions with a top-5 pharmaceutical company to supply them with data for 2,000 osteoporosis patients.
Location: United States, Massachusetts, Cambridge